论文部分内容阅读
目的观察复方罗布麻片与胺碘酮配伍治疗冠心病室性心律失常的临床效果。方法选取2013年5月-2015年5月冠心病室性心律失常患者240例,随机分为观察组与对照组各120例,对照组予胺碘酮治疗,观察组在对照组基础上加用复方罗布麻片治疗,比较2组临床效果及不良反应发生情况。结果观察组总有效率95.83%明显优于对照组的70.83%,差异有统计学意义(P<0.05)。观察组不良反应发生率36.67%,对照组不良反应发生率37.50%,2组比较差异无统计学意义(P>0.05)。临床观察显示复方罗布麻片与胺碘酮联合用药不良反应小。结论复方罗麻布片联合胺碘酮治疗冠心病室性心律失常疗效优于单独使用胺碘酮,且不良反应小,值得临床推广应用。
Objective To observe the clinical effect of Compound Apocynum Vetiver and Amiodarone in the treatment of ventricular arrhythmia in patients with coronary heart disease. Methods From May 2013 to May 2015, 240 patients with coronary heart disease and ventricular arrhythmia were randomly divided into observation group and control group, 120 cases in each group. The control group was treated with amiodarone. The observation group was added on the basis of the control group Compound Apocynum tablets treatment, the clinical effects and adverse reactions in two groups were compared. Results The total effective rate was 95.83% in the observation group was significantly better than 70.83% in the control group, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 36.67%, and the incidence of adverse reactions in the control group was 37.50%. There was no significant difference between the two groups (P> 0.05). Clinical observation showed that compound Apocynum combined with amiodarone adverse reactions small. Conclusions The compound Luomabu tablets combined with amiodarone in the treatment of coronary heart disease ventricular arrhythmias better than the single use of amiodarone, and adverse reactions, worthy of clinical application.